CLINICAL TRIALS PROFILE FOR TROGLITAZONE
✉ Email this page to a colleague
All Clinical Trials for TROGLITAZONE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00003058 ↗ | Troglitazone in Treating Patients With Liposarcoma | Completed | National Cancer Institute (NCI) | Phase 2 | 1997-06-01 | Troglitazone may help liposarcoma cells develop into normal cells. This was a single arm, open-label study with a two-stage design to evaluate troglitazone in patients with liposarcoma stratified by histologic subtype. |
NCT00003058 ↗ | Troglitazone in Treating Patients With Liposarcoma | Completed | Dana-Farber Cancer Institute | Phase 2 | 1997-06-01 | Troglitazone may help liposarcoma cells develop into normal cells. This was a single arm, open-label study with a two-stage design to evaluate troglitazone in patients with liposarcoma stratified by histologic subtype. |
NCT00116545 ↗ | TART - Troglitazone Atherosclerosis Regression Trial | Completed | Parke-Davis | Phase 2/Phase 3 | 1997-01-01 | The purpose of this study is to determine if troglitazone reduces the progression of early preintrusive carotid atherosclerosis in insulin-requiring diabetes patients. |
NCT00242177 ↗ | Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability | Completed | Takeda Pharmaceuticals North America, Inc. | Phase 1 | 2003-10-01 | The purpose of this study is to determine whether an already FDA approved drug is safe and tolerable in Relapsing Remitting Multiple Sclerosis patients. |
NCT00242177 ↗ | Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability | Completed | University of Illinois at Chicago | Phase 1 | 2003-10-01 | The purpose of this study is to determine whether an already FDA approved drug is safe and tolerable in Relapsing Remitting Multiple Sclerosis patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TROGLITAZONE
Condition Name
Clinical Trial Locations for TROGLITAZONE
Trials by Country
Clinical Trial Progress for TROGLITAZONE
Clinical Trial Phase
Clinical Trial Sponsors for TROGLITAZONE
Sponsor Name
Sponsor Name for TROGLITAZONE | |
Sponsor | Trials |
Canadian Institutes of Health Research (CIHR) | 3 |
Drug Safety and Effectiveness Network, Canada | 3 |
Canadian Network for Observational Drug Effect Studies, CNODES | 3 |
[disabled in preview] | 4 |
This preview shows a limited data set Subscribe for full access, or try a Trial |